Acasti Pharma (ACST) Reports Q1 Loss of $0.18

Acasti Pharma (NASDAQ: ACST) reported Q1 EPS of ($0.18), versus ($0.21) reported last year. Revenue for the quarter came in at $21 thousand, versus $178 thousand reported last year.

For earnings history and earnings-related data on Acasti Pharma (ACST) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance